Stem Cell — At least 4 weeks of RLT Vet™ therapy is recommended prior to stem cell injection in order to prepare tissue environment and make easier cell viability. 90 days post stem cell stabilization, RLT Vet™ treatment can be useful to promote physiological healing of tissue (correct alignment of collagen\ fibers, correct kind of collagen fibers, correct physiological chemical composition of extracellular matrix.)
PRP — Platelet-Rich Plasma — RLT Vet™ is recommended for use for approximately 2 weeks prior to PRP injection, typically used adjectively with acute injuries, all tissue types. RLT Vet™ should be administered while bone marrow is being cultured and before injection at the 30 day mark. With RLT Vet™, the fibrocyte, an element of the blood, is able to transform to a tissue-based fibroblast. The fibroblast, unlike the fibrocyte, is sensitive to stimulation by the RLT Vet™, which results in expression of growth factors and improved healing. Current research suggests, the effect of RLT Vet™ is to reactivate a chronic lesion with result of increasing fibroblast migration to the injury site and enhanced healing. RLT Vet™ allows the chronic lesion to revert to a more acute stage making PRP injection more effective. RLT Vet™ treatment can resume at approximately 30 days post PRP injection.
IRAP© — Interleukin-1 Receptor Antagonist Protein — RLT Vet™ treatment is recommended for daily use for 7 to 10 days prior to IRAP injection to reduce inflammation causing the IRAP therapy to be more affective on more severe osteoarthritis. RLT Vet™ treatment can be applied immediately following IRAP to promote healing.
Tildren® — RLT Vet™ treatment is approved for use with Tilden injection therapy. The rationale is laser improves the viability of the drug and increases blood supply and microcirculation of the bone, reducing risk of ischemic
Shockwave — RLT Vet™ is recommended for use 7-10 days post Shockwave. The rationale is to improve the environment where fibroblasts are present (PH balance, temperature, decrease Free Radicals, possible reduction of toxicity within the cells when present.) This process allows tissue regeneration through fibroblast differentiation.
Corticosteroids — Contraindicated for use with RLT Vet™ treatment. RLT Vet™ treatment can start post 30 days after injection of corticosteroids. They are catabolic in action which is contrary to regenerative therapy that is anabolic.
NSAIDS — Non-Steroidal Anti- Inflammatory Drug — Approved for use with RLT Vet™ treatment.
Supplements — It is recommended to only use basic nutritional level. This will aid in keeping horse more calm.
Aspirin — When treating with RLT Vet™, it is recommended to give 60 grains (4 grams) of oral aspirin to be continued until at least 3 months after treatment.
PRP — Platelet-Rich Plasma — RLT Vet™ is recommended for use for approximately 2 weeks prior to PRP injection, typically used adjectively with acute injuries, all tissue types. RLT Vet™ should be administered while bone marrow is being cultured and before injection at the 30 day mark. With RLT Vet™, the fibrocyte, an element of the blood, is able to transform to a tissue-based fibroblast. The fibroblast, unlike the fibrocyte, is sensitive to stimulation by the RLT Vet™, which results in expression of growth factors and improved healing. Current research suggests, the effect of RLT Vet™ is to reactivate a chronic lesion with result of increasing fibroblast migration to the injury site and enhanced healing. RLT Vet™ allows the chronic lesion to revert to a more acute stage making PRP injection more effective. RLT Vet™ treatment can resume at approximately 30 days post PRP injection.
IRAP© — Interleukin-1 Receptor Antagonist Protein — RLT Vet™ treatment is recommended for daily use for 7 to 10 days prior to IRAP injection to reduce inflammation causing the IRAP therapy to be more affective on more severe osteoarthritis. RLT Vet™ treatment can be applied immediately following IRAP to promote healing.
Tildren® — RLT Vet™ treatment is approved for use with Tilden injection therapy. The rationale is laser improves the viability of the drug and increases blood supply and microcirculation of the bone, reducing risk of ischemic
Shockwave — RLT Vet™ is recommended for use 7-10 days post Shockwave. The rationale is to improve the environment where fibroblasts are present (PH balance, temperature, decrease Free Radicals, possible reduction of toxicity within the cells when present.) This process allows tissue regeneration through fibroblast differentiation.
Corticosteroids — Contraindicated for use with RLT Vet™ treatment. RLT Vet™ treatment can start post 30 days after injection of corticosteroids. They are catabolic in action which is contrary to regenerative therapy that is anabolic.
NSAIDS — Non-Steroidal Anti- Inflammatory Drug — Approved for use with RLT Vet™ treatment.
Supplements — It is recommended to only use basic nutritional level. This will aid in keeping horse more calm.
Aspirin — When treating with RLT Vet™, it is recommended to give 60 grains (4 grams) of oral aspirin to be continued until at least 3 months after treatment.